Bibby Scientific’s Integrity 10 Reaction Station helps scientists to speed up drug development research

NewsGuard 100/100 Score

Analytical scientists at the University of Lincoln’s School of Pharmacy are accelerating their drug development research thanks to Bibby Scientific’s Integrity 10 Reaction Station, which enables different reactions to be performed simultaneously with varied process conditions. Bibby’s Reaction Stations are designed for screening and optimising ten different reactions in parallel across individually controlled units for applications including solubility and protein crystallisation.

The Integrity 10 Reaction Station offers precise control of temperature and stirring speed for each individual reaction, for sample volumes ranging from 1 - 25 mL and temperatures ranging from -30°C to 150°C. It is easily operated with a colour touchscreen and has accessories including multi-infrared probes, and attachments for refluxing and working under inert conditions.

“The Integrity 10 is perfect for my research because I’m trying to crystallise problematic compounds, so I need to change a lot of parameters for each experiment,” said Paul Stainton, PhD student at the University of Lincoln. “The Reaction Station is helping to move my research along much more quickly, because it allows me to perform ten different experiments simultaneously with different parameters.”

Running simultaneous reactions not only saves valuable time, materials and labour, but can also generate more comparable and higher quality scientific data.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings